16 research outputs found
PND12 COST-EFFECTIVENESS OF RASAGILINE VERSUS ROPINIROLE EXTENDED RELEASE IN DELAYING LEVODOPA IN THE TREATMENT OF EARLY PARKINSON'S DISEASE IN THE UNITED STATES
Get PDFAdesão à medicação em pacientes com doença de Parkinson atendidos em ambulatório especializado
Full text linkPND1 INDIRECT COMPARISON OF ADVERSE EVENTS AND DROPOUT RATES FOR EARLY PARKINSON'S DISEASE (PD) MONOTHERAPY TRIALS: PRAMIPEXOLE, ROPINIROLE AND RASAGILINE
No full textPND24 TREATMENT OF ADVANCED PARKINSON'S DISEASE IN THE UNITED STATES: A COST-UTILITY MODEL
No full textPND34 DISEASE BURDEN AND TREATMENT PATTERNS OF PARKINSON'S DISEASE IN A LONG TERM CARE SETTING
Get PDFPND34 DISEASE BURDEN AND TREATMENT PATTERNS OF PARKINSON'S DISEASE IN A LONG TERM CARE SETTING
No full text
PND21 COST-EFFECTIVENESS OF RASAGILINE COMPARED TO OTHER FIRST LINE TREATMENT OPTIONS OF EARLY PARKINSON'S DISEASE IN THE UNITED STATES
Get PDFPND21 COST-EFFECTIVENESS OF RASAGILINE COMPARED TO OTHER FIRST LINE TREATMENT OPTIONS OF EARLY PARKINSON'S DISEASE IN THE UNITED STATES
No full textPND12 COST-EFFECTIVENESS OF RASAGILINE VERSUS ROPINIROLE EXTENDED RELEASE IN DELAYING LEVODOPA IN THE TREATMENT OF EARLY PARKINSON'S DISEASE IN THE UNITED STATES
No full text
